Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Dividends payables (2024 - 2026)

Envoy Medical's Dividends payables history spans 3 years, with the latest figure at $5.1 million for Q1 2026.

  • On a quarterly basis, Dividends payables changed N/A to $5.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.1 million, a N/A change, with the full-year FY2025 number at $3.8 million, up 446.74% from a year prior.
  • Dividends payables hit $5.1 million in Q1 2026 for Envoy Medical, up from $3.8 million in the prior quarter.
  • Over the last five years, Dividends payables for COCH hit a ceiling of $5.1 million in Q1 2026 and a floor of $691000.0 in Q4 2024.
  • Historically, Dividends payables has averaged $2.7 million across 3 years, with a median of $2.6 million in 2025.
  • The widest YoY moves for Dividends payables: up 446.74% in 2025, down 446.74% in 2025.
  • Tracing COCH's Dividends payables over 3 years: stood at $691000.0 in 2024, then soared by 446.74% to $3.8 million in 2025, then skyrocketed by 35.73% to $5.1 million in 2026.
  • Business Quant data shows Dividends payables for COCH at $5.1 million in Q1 2026, $3.8 million in Q4 2025, and $2.6 million in Q3 2025.